Keating Financial Advisory Services’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.76K Sell
54
-3
-5% -$363 ﹤0.01% 1481
2026
Q1
$9.32K Buy
57
+22
+63% +$3.38K ﹤0.01% 1164
2025
Q4
$6.09K Buy
+35
New +$6.39K ﹤0.01% 1230

Other funds holding INSM

Keating Financial Advisory Services's INSM Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its Insmed (INSM) stake by 5.3% in Q2 2026, selling an estimated $363 and leaving 54 shares worth $5.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

Keating Financial Advisory Services first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.32K in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Keating Financial Advisory Services held 54 shares of Insmed worth $5.76K as of Q2 2026.
  • Keating Financial Advisory Services sold 3 Insmed shares in Q2 2026, an estimated $363.
  • Insmed made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1481 holding.
  • Keating Financial Advisory Services first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's Insmed position peaked at $9.32K in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.